Greenrise welcomes cannabis policy developments in Germany
The company is preparing for the potential legalisation of adult-use cannabis in Germany.
The company is preparing for the potential legalisation of adult-use cannabis in Germany.
Cannaray recently closed a £10 million funding round to expand its medical cannabis arm.
Khiron has posted record 2022 Q1 numbers that included revenue of $4.6 million, a 65 per cent increase from Q1 2021.
Materia Malta is the first company to export medical cannabis from Malta for sale in another country.
Hearings are planned throughout 2022 to discuss the country’s new approach to cannabis legislation.
Cantourage and Clever Leaves have intensified their strategic partnership in the country.
“Most countries around Europe will be following the German lead,” writes Mike Sassano, CEO of Somai Pharmaceuticals.
The global medical cannabis company is set to acquire Pharmadrug GmbH from its parent company, PharmaDrug Inc.
FEARS that German health ministers may be dragging their feet on rolling out cannabis legislation were definitively quashed earlier this
The sales estimates were based on a survey of research firms covering the financial outlook of Aurora.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.